Viking Therapeutics (VKTX): The pure-play GLP-1 development company reported promising Phase 2 data for its own obesity candidate, VK2735
Table 1: Initial use restrictions for Wegovy by commercial plans Source: Clarivate Fingertip Restrictions and payers respective prior authorization documents In addition to a relatively light hand in restricting access, Aetna, Cigna, and Anthem list Wegovy on Tier 2 of their commercial and employer formularies, reflecting widespread coverage for the drug (Fingertip Analytics, accessed February 2024)
Advertisement Research ArticleMetabolismNeuroscience Open Access | 10.1172/JCI178239 1 Shenzhen Key Laboratory of Drug Addiction, Shenzhen Neher Neural Plasticity Laboratory, ShenzhenHong Kong Institute of Brain Science, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China
Back to Journals Diabetes, Metabolic Syndrome and Obesity Volume 17 The Regulation of Metabolic Homeostasis by Incretins and the Metabolic Hormones Produced by Pancreatic Islets Authors Reed J, Bain SC , Kanamarlapudi V Received 16 January 2024 Accepted for publication 7 May 2024 Published 13 June 2024 Volume 2024:17 Pages 24192456 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 4 Editor who approved publication: Prof
This is a core part of the patient guidance at Pure Med Spa when discussing GLP-1 reproductive health